MedPath
HSA Approval

ONDAVELL FILM-COATED TABLET 8MG

SIN15004P

ONDAVELL FILM-COATED TABLET 8MG

ONDAVELL FILM-COATED TABLET 8MG

May 5, 2016

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A04AA01

ondansetron

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

PT. Novell Pharmaceutical Laboratories

Active Ingredients

Ondansetron Hydrochloride Dihydrate 10.000mg eqv Ondansetron

8mg

Ondansetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ONDAVELL FILM-COATED TABLET 8MG - HSA Approval | MedPath